Evaluation of Derived Hematological Markers across Various Groups of Bethesda Cervical Cytology
Rachagiri Suneel, Kamali Annamalai, Murugesan Rajeswari, Poongodi Rajagopal, Prashant Pranesh Joshi, Jyotsna Naresh BhartiAbstract
Aim:
To evaluate the relationship between Bethesda Cervical Cytology categories and selected hematological indices and to introduce a new composite marker, the cervical inflammation index (CII; neutrophil-to-lymphocyte ratio [NLR] + platelet-to-lymphocyte ratio [PLR] + systemic immune-inflammation index [SII]).
Materials and Methods:
This retrospective, record-based study included cervical cytology smears reported under the Bethesda System (The Bethesda System for Reporting Cervical Cytology) between January 2022 and June 2025. Cases were grouped as negative for intraepithelial lesions or malignancy (NILM), NILM with dense inflammation, NILM with bacterial vaginosis (BV), NILM with
Results:
As the data were non-normally distributed, results are presented as median (interquartile range). Significant variation across Bethesda groups was observed for NLR, MLR, SII, CII, MPV, and PDW (
Conclusion:
Derived hematological parameters show distinct variation across Bethesda categories, with several indices elevated in high-risk lesions. These easily obtainable markers may serve as cost-effective adjuncts for patient stratification and contribute to the early detection of premalignant or malignant cervical lesions, pending further validation.